Quantcast

Toxicogenomics and classic toxicology: how to improve prediction and mechanistic understanding of human toxicity.

Research paper by Donna L DL Mendrick

Indexed on: 02 May '08Published on: 02 May '08Published in: Methods in molecular biology (Clifton, N.J.)



Abstract

The field of toxicogenomics has been advancing during the past decade or so since its origin. Most pharmaceutical companies are using it in one or more ways to improve their productivity and supplement their classic toxicology studies. Acceptance of toxicogenomics will continue to grow as regulatory concerns are addressed, proof of concept studies are disseminated more fully, and internal case studies show value for the use of this new technology in concert with classic testing.